Skip to content

8-KAccepted Feb 2, 8:30 AM ET

RespireRx Pharmaceuticals Inc. 8-K

RespireRx Pharmaceuticals Inc.

Accepted (ET)

8:30 AM

Feb 2, 2024

Filed

Feb 2, 2024

Documents

18

Size

533.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.